Strive Financial Group’s Eli Lilly LLY Stock Holding History

Strive Financial Group’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4	Closed	-$41K	–	928
2026 Q1	$41K	Buy	+4	New	+$4.05K	0.02%	246

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Strive Financial Group's LLY Position: Q2 2026 in Review

Strive Financial Group increased its Eli Lilly (LLY) stake by 161% in Q2 2026, buying an estimated $2.82M and bringing the position to 4,477 shares worth $5.37M. The position accounts for 2.33% of the portfolio, ranked #10.

Strive Financial Group first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 3,504 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Strive Financial Group held 4,477 shares of Eli Lilly worth $5.37M as of Q2 2026.
Strive Financial Group bought 2,762 Eli Lilly shares in Q2 2026, an estimated $2.82M.
Eli Lilly made up 2.33% of Strive Financial Group's portfolio in Q2 2026, its #10 holding.
Strive Financial Group first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
3,504 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Strive Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.